Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Gastric Carcinoma 1

Interventions

Oxaliplatin 152Fluorouracil 138Gemcitabine 118Bevacizumab 117Leucovorin 107Specimen Handling 105Capecitabine 96pembrolizumab 91Magnetic Resonance Spectroscopy 83Nivolumab 79Cisplatin 79Irinotecan 72durvalumab 64Cetuximab 62Biopsy 61Paclitaxel 60130-nm albumin-bound paclitaxel 60atezolizumab 46Radiotherapy 46Albumin-Bound Paclitaxel 37Taxes 36Carboplatin 36Folfox protocol 35Drug Therapy 32Cyclophosphamide 30lenvatinib 29dehydroftorafur 29tislelizumab 27sintilimab 27Radiation 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
ferric carboxymaltose × Gastrointestinal × 90 days × Clear all
NCT05226169 2026-04-03

Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

Asan Medical Center

Phase 3 Recruiting
330 enrolled
Gastrointestinal

Advanced Gastric Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡